Market News

Premier Energies shares in focus as promoters sell stake worth Rs 2,289 crore. Check top buyers

Promoter family members of Premier Energies sold shares worth around Rs 2,289 crore through a block deal, while institutional investors, including Quant Mutual Fund and Nomura, picked up stakes. The development comes amid strong investor interest in renewable energy and domestic solar manufacturing, supported by robust earnings growth and aggressive capacity expansion plans.

Premier Energies bulk deal: Promoters sell stake worth Rs 2,289 crore; Quant, Nomura among top buyers

Premier Energies' promoters divested shares worth nearly Rs 2,289 crore to institutional investors, including Smallcap World Fund and Quant Mutual Fund. This move coincides with heightened interest in India's solar manufacturing sector, driven by policy support and robust earnings. The company is aggressively expanding its module and cell capacities, with analysts maintaining a positive outlook.

Anupam Rasayan to acquire up to 43 pc stake in Bliss GVS Pharma for around Rs 1,369 cr

Specialty chemicals maker Anupam Rasayan India is set to acquire up to 43.3% of Bliss GVS Pharma for an estimated Rs 1,369.51 crore, with an open offer for an additional 26%. This strategic move aims to strengthen Anupam Rasayan's presence across the pharmaceutical value chain, from key starting materials to finished dosage formulations.

Anupam Rasayan enters formulations business with ₹1,369 cr Bliss GVS Pharma acquisition

Anupam Rasayan will acquire up to 74.2% stake in Bliss GVS Pharma, strengthening its presence across the pharmaceutical value chain and expanding its reach in regulated global markets.

Colgate-Palmolive India leans on premium products, advertising to drive growth

Colgate-Palmolive India is boosting investments in premium products and advertising. The company prioritizes volume-driven growth over margin expansion. This strategy aims to capture rising consumer demand for higher-value oral care. Urban demand is recovering, benefiting premium offerings. E-commerce and quick commerce are significant growth drivers, especially for premium products.

Venus Remedies receives Saudi FDA approval for Plerixafor

Venus Remedies has received Marketing Authorization from the Saudi Food and Drug Authority (SFDA) for Plerixafor. This is the first Marketing Authorization Venus Remedies has secured for Plerixafor anywhere in the world. It is also a deliberate step in the company's move toward complex, higher-value specialty injectables in oncology and critical care, replacing reliance on commodity injectable volumes with diifferentiated therapies in regulated markets.

Aditya Birla Group bets big on IPL boom, says media rights frenzy is far from over

Aditya Birla Group sees strong future growth for Indian sports. The group believes IPL media rights will keep increasing in value. This is despite current worries about fewer bidders. India's economy and sports viewership are rising. Premium sports assets are also scarce. This supports future valuations. The group recently bought Royal Challengers Bengaluru. They are optimistic about the long-term trend.

INOXGFL leads race for Vena's India biz buyout; Proposed deal may give Rs 4,500-5,000 crore enterprise value

INOXGFL Group is poised to acquire Vena Energy's Indian renewable energy business. The deal is valued between ₹4,500-5,000 crore. This move signifies INOXGFL's aggressive expansion in India's clean energy sector. The conglomerate has recently made several strategic acquisitions, bolstering its renewable energy portfolio. This acquisition further strengthens its position in the rapidly growing market.

Sensex Today | Stock Market LIVE Updates: GIFT Nifty trades lower; Muthoot Fin in focus

Sensex Today | Stock Market LIVE Updates: The next Nifty hurdle is its 20-DMA, just near the mark of 23,900. That's another 200 points away. The Nifty Bank will be the index to watch as any further short-covering could propel both indices higher. The Nifty support is back at 23,500 and the index is set for a weekly advance as well.

Abakkus trims banking exposure, adds solar and power-linked capital goods stocks

Aman Chowhan, Fund Manager at Abakkus Asset Manager, which manages assets worth nearly $2.06 billion, said the sharp market rebound over the past few weeks has caught many investors by surprise, even as the fund stayed selectively bullish through the correction. The Mumbai-based AMC increased exposure to renewable energy, power-linked capital goods and select metal plays, while trimming some banking exposure. Disclaimer: The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.

UPL Share Price Live Updates: UPL's beta value highlights its market behavior

Baroda BNP Paribas MF sees easing crude boosting rate-sensitive stocks, chemicals

Baroda BNP Paribas Mutual Fund Senior Fund Manager Jitendra Sriram said softer crude prices could improve sentiment for India and support interest rate-sensitive sectors. He believes refining, oil marketing and select specialty chemical companies may benefit if West Asia tensions ease. Sriram also cautioned that higher raw material and logistics costs may pressure corporate earnings over the next few quarters despite resilient recent results. Disclaimer: The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.